Prostate cancer awareness and screening in the UK have seen a notable increase following public disclosures by several high-profile figures about their diagnoses. Prostate Cancer UK, a leading charity focused on the disease, reported significant spikes in the use of its online risk checker tool, which helps men assess their likelihood of developing prostate cancer.
The charity’s 30-second risk checker, launched in 2020, has now been completed by over five million men. Usage surges have closely followed announcements by celebrities revealing their battles with prostate cancer. For instance, after ex-Prime Minister Lord David Cameron disclosed his diagnosis in 2025, daily visits to the tool jumped from around 2,000 to more than 22,000 in the week immediately afterward. Similarly, when former Top Gear presenter Jeremy Clarkson announced his diagnosis in June 2025 during episodes of his show "Clarkson’s Farm," daily traffic to the checker rose dramatically from approximately 8,400 to 51,000.
Other public figures, including Sir Chris Hoy, former footballer John Barnes, and actor Sir Tony Robinson, have also publicly shared their experiences with prostate cancer. Sir Chris Hoy’s announcement in late 2024 that he was facing stage 4 terminal prostate cancer sparked a considerable response, with about 280,000 men using the risk checker within two months of his disclosure. Hoy has been vocal about advocating for increased screening among men in high-risk groups.
Amy Rylance, director of health services, equity, and improvement at Prostate Cancer UK, emphasized that prostate cancer remains the most common cancer among men in the UK. She noted that many cases are still diagnosed incidentally and often too late for effective treatment. Rylance highlighted the important role celebrity disclosures play in encouraging earlier detection, stating that these stories have inspired numerous men to check their risk—potentially saving lives through earlier intervention.
Both Clarkson and Lord Cameron, who are now in remission, have joined calls for the government to implement a targeted national screening program. Along with other survivors, they have urged Health Secretary Yvette Cooper to take immediate action rather than waiting for further data, emphasizing the urgency of reducing mortality rates from the disease. Clarkson has reiterated the message that assessing prostate cancer risk is straightforward and could be life-saving.
The increased public engagement with prostate cancer screening tools following celebrity diagnoses illustrates the influence of high-profile advocates in health awareness campaigns. While views on the scope and implementation of national screening programs vary, the current trend highlights a broader recognition of the benefits of early detection and the ongoing efforts to reduce the impact of prostate cancer in the UK.